REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 31 filers reported holding REXAHN PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $47,000 | -32.9% | 334,492 | 0.0% | 0.00% | – |
| Q3 2016 | $70,000 | -16.7% | 334,492 | 0.0% | 0.00% | – |
| Q2 2016 | $84,000 | -23.6% | 334,492 | 0.0% | 0.00% | – |
| Q1 2016 | $110,000 | -9.1% | 334,492 | 0.0% | 0.00% | – |
| Q4 2015 | $121,000 | -30.5% | 334,492 | 0.0% | 0.00% | – |
| Q3 2015 | $174,000 | -14.3% | 334,492 | 0.0% | 0.00% | – |
| Q2 2015 | $203,000 | -16.8% | 334,492 | 0.0% | 0.00% | – |
| Q1 2015 | $244,000 | +597.1% | 334,492 | +559.9% | 0.00% | – |
| Q4 2014 | $35,000 | +2.9% | 50,692 | +61.7% | 0.00% | – |
| Q1 2014 | $34,000 | – | 31,340 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 20,000 | $57,000 | 0.02% |